Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KROS | Keros Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | $11.5M | Feb 23, 2024 | ||
ELOX | Eloxx Pharmaceuticals, Inc. | Director | Jun 15, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|